Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
CVD mortality similar with diuretic, ACE inhibitor, or calcium channel blocker
Dec 04, 2023
Those randomly assigned to receive ACE inhibitor had an increased risks for stroke mortality and fatal and nonfatal hospitalized stroke versus the diuretic group.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Statin initiation cuts mortality in older adults with chronic kidney disease
Jan 05, 2024
The findings were seen among older adults with stage 3 to 4 disease with no prior atherosclerotic cardiovascular disease.
Statin use increased from 1999-2000 to 2013-2014, then plateaued
Dec 04, 2023
No change was seen in the proportion using statins from 2013-2014 to 2017-2018 for those with diabetes and with ASCVD risk greater than 20%.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
AI could play role in preventing prescribing of unnecessary drugs in older adults
By
Kristen Fischer
Apr 22, 2024
A new study finds that artificial intelligence could encourage doctors to stop prescribing drugs that aren’t necessary.